Altimmune Inc Revenue Growth Rates (ALT), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Altimmune inc   (NASDAQ: ALT)
 

ALT's Revenue Growth by Quarter and Year

Altimmune Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ALT Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 0.00
1st Quarter March 0.00
FY 0.00

ALTs Annual Revenue
Altimmune Inc 's Revenue in the fiscal year 2025 $ 0.04 millions
Altimmune Inc 's Revenue in the fiscal year 2024 $ 0.02 millions
Altimmune Inc 's Revenue in the fiscal year 2023 $ 0.43 millions
Altimmune Inc 's Revenue in the fiscal year 2022 $ -0.07 millions
Altimmune Inc 's Revenue in the fiscal year 2021 $ 4.61 millions




ALT Revenue second quarter 2026 Y/Y Growth Comment
Altimmune inc in the second quarter 2026 recorded of $ 0.00 millions.

According to the results reported in the second quarter 2026, Altimmune Inc achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Altimmune Inc ' s Revenue meltdown of -100% ranks overall at the positon no. in the second quarter 2026.


ALT Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 200 % -75 % -
3rd Quarter September - 0 % -97.22 % -
2nd Quarter June - 0 % 0 % -97.06 %
1st Quarter March - 0 % -50 % -60 %
FY   - 50 % -90.7 % -

Financial Statements
Altimmune Inc 's second quarter 2026 Revenue $ 0.00 millions ALT's Income Statement
Altimmune Inc 's second quarter 2025 Revenue $ 0.01 millions Quarterly ALT's Income Statement


ALT Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 200 % 0 % -88.89 %
3rd Quarter September - 0 % 0 % 3500 %
2nd Quarter June - 0 % 0 % -50 %
1st Quarter March - 0 % -75 % -
FY (Year on Year)   - 50 % -90.7 % -


Back to ALT Growth rate Comparisons >> Back to ALT Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Altimmune Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ALT's II. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ALT's II. Quarter Q/Q Revenue Comment


Altimmune Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.04 $ 0.02 $ 0.02
Y / Y Revenue Growth (TTM) - - 105 % -61.54 % -95.11 %
Year on Year Revenue Growth Overall Ranking # # # 3794 # 3904 # 3953
Seqeuential Revenue Change (TTM) - - 105 % 0 % 0 %
Seq. Revenue Growth (TTM) Overall Ranking # # 209 # 3794